Efficient delivery of Bcl-2-targeted siRNA using cationic polymer nanoparticles: downregulating mRNA expression level and sensitizing cancer cells to anticancer drug.
about
Polymeric nanoparticles for targeted treatment in oncology: current insightsNanometer-scale siRNA carriers incorporating peptidomimetic oligomers: physical characterization and biological activity.Direct interrogation of DNA content distribution in nanoparticles by a novel microfluidics-based single-particle analysis.The polyamidoamine-mediated inhibition of bcl-2 by small hairpin RNA to induce apoptosis in human lens epithelial cells.The effect of interleukin 36 gene therapy in the regression of tumor.Synthesis of polysaccharide-block-polypeptide copolymer for potential co-delivery of drug and plasmid DNA.Co-delivery of siRNA and therapeutic agents using nanocarriers to overcome cancer resistance.Novel polymer micelle mediated co-delivery of doxorubicin and P-glycoprotein siRNA for reversal of multidrug resistance and synergistic tumor therapy.Bioresponsive polymers for the delivery of therapeutic nucleic acids.Nanopreparations to overcome multidrug resistance in cancer.Nanodrug delivery in reversing multidrug resistance in cancer cells.Delivery of therapeutics using nanocarriers for targeting cancer cells and cancer stem cells.Drug and gene co-delivery systems for cancer treatment.Inhibition of cell proliferation through an ATP-responsive co-delivery system of doxorubicin and Bcl-2 siRNA.Preliminary study of a novel transfection modality for in vivo siRNA delivery to vocal fold fibroblasts.Gene therapy with IL-12 induced enhanced anti-tumor activity in fibrosarcoma mouse model.EGF-modified mPEG-PLGA-PLL nanoparticle for delivering doxorubicin combined with Bcl-2 siRNA as a potential treatment strategy for lung cancer.Nanoparticle-mediated co-delivery of chemotherapeutic agent and siRNA for combination cancer therapy.The Tumor Microenvironment as a Barrier to Cancer Nanotherapy.Functionalization of the 3'-ends of DNA and RNA strands with N-ethyl-N-coupled nucleosides: a promising approach to avoid 3'-exonuclease-catalyzed hydrolysis of therapeutic oligonucleotides.Optically traceable solid lipid nanoparticles loaded with siRNA and paclitaxel for synergistic chemotherapy with in situ imaging.Tailoring of physicochemical properties of nanocarriers for effective anti-cancer applications.Efficient intracellular siRNA delivery by ethyleneimine-modified amphiphilic macromolecules.Cationic cholesterol-modified gelatin as an in vitro siRNA delivery vehicle.The generation of compartmentalized nanoparticles containing siRNA and cisplatin using a multi-needle electrohydrodynamic strategy.Targeted Co-delivery of PTX and TR3 siRNA by PTP Peptide Modified Dendrimer for the Treatment of Pancreatic Cancer.Alginate modified nanostructured calcium carbonate with enhanced delivery efficiency for gene and drug delivery
P2860
Q28087243-5824D509-1D75-432B-A09E-56C6AE3338F4Q33633338-00244F76-77D1-44C9-9D63-BE1CBB8FC01BQ34050308-B47D3DD3-4295-4C8E-8E7F-5102C87DB324Q34134038-78481495-3F44-496B-950B-F5229A141714Q35015898-CC45829D-60F3-4D15-A8E5-B7E29819D62EQ35575232-13DE30E9-2C70-4CFB-91EF-ECC3E01FD2C3Q35924301-971A9C96-A0F0-4246-9945-45F58E634515Q36748360-93243156-F26E-4B52-961F-9D0EAC17CAA8Q37763677-963A5C55-7055-487C-9217-C6D711927E41Q38131264-6404B80F-7CFA-4B9B-A677-F0678CB17975Q38234908-9DDC6736-881D-45F9-BCED-53444E02387AQ38322466-4269179C-29BC-4A79-BC69-68CC1381B1AAQ38556764-C105DF22-0605-4B7A-B197-405032DE321FQ38696439-3DBE7825-1039-4F7D-81DE-A9849F0FE921Q38725307-74D69DD5-147F-4F23-A2F5-81AAB56609E4Q38804304-5B89E797-1DA5-43CD-8FF3-374C76CB2095Q38806059-9DC9C9F5-8D56-41E0-A7E4-7A26C80B0813Q38874499-3DA38ED1-9422-4767-9240-9CAE0D6398FEQ38980088-2D1ED333-D5C7-40BF-B017-4BD45AD8D51CQ39202309-0B464EE4-5F25-4354-9EF8-EAB3512AF194Q39237850-DAE9E4FF-7803-4629-8A3C-5CE0E3A12950Q39393477-C761981C-205D-4A1C-8468-8695E735C524Q39500124-4DB1DFBF-A971-407A-AF48-56B4098EE7F1Q46664128-4EFBD1D6-4E2F-4332-8771-39DCAC628E21Q48235071-C0D4D115-1BBA-4312-9038-26793D86E7E5Q51131993-3E61F218-7459-489E-BD75-472F6471809EQ57218839-13FA8D8D-DCB9-4C24-A006-1E9FFA3EFCC6
P2860
Efficient delivery of Bcl-2-targeted siRNA using cationic polymer nanoparticles: downregulating mRNA expression level and sensitizing cancer cells to anticancer drug.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Efficient delivery of Bcl-2-ta ...... ncer cells to anticancer drug.
@en
Efficient delivery of Bcl-2-ta ...... ncer cells to anticancer drug.
@en-gb
Efficient delivery of Bcl-2-ta ...... ncer cells to anticancer drug.
@nl
type
label
Efficient delivery of Bcl-2-ta ...... ncer cells to anticancer drug.
@en
Efficient delivery of Bcl-2-ta ...... ncer cells to anticancer drug.
@en-gb
Efficient delivery of Bcl-2-ta ...... ncer cells to anticancer drug.
@nl
prefLabel
Efficient delivery of Bcl-2-ta ...... ncer cells to anticancer drug.
@en
Efficient delivery of Bcl-2-ta ...... ncer cells to anticancer drug.
@en-gb
Efficient delivery of Bcl-2-ta ...... ncer cells to anticancer drug.
@nl
P2093
P50
P356
P1433
P1476
Efficient delivery of Bcl-2-ta ...... ncer cells to anticancer drug.
@en
P2093
Cyrus W Beh
Wei Yang Seow
Yi-Yan Yang
P356
10.1021/BM801109G
P577
2009-01-01T00:00:00Z